Karl-Johan Malmberg, Director, Center of Excellence: Precision Immunotherapy Alliance at The University of Oslo, shared a post on LinkedIn:
“Congrats Lamberto Torralba-Raga. We are very proud of you! ECHO is a really cool project combining ex vivo and in vivo editing for precision immunotherapy.”
Lamberto Torralba-Raga, Scientist at Oslo universitetssykehus, shared Karl-Johan Malmberg’s post, adding:
“Our project ECHO: Epigenetic Cellular Hack for Oncotherapy has been funded by the Research Council of Norway under the Radical Research Ideas call, and was even highlighted among the awarded projects.
I’m genuinely grateful to the Research Council for investing in bold, high-risk, high-reward ideas and for supporting early-career researchers willing to explore unconventional paths. This kind of trust is what enables new concepts to be tested and transformed into future research programs.
Many thanks as well to Karl-Johan Malmberg (also awarded on this call!) and Lise Kveberg for outstanding support, the fantastic Malmberg group in Oslo and Stockholm, collaborators and the inspiring environment at the Institute for Cancer Research / Oslo University Hospital / Precision Immunotherapy Alliance, PRIMA.
Excited for what’s ahead. We keep working.
Original news (Norwegian).
Read more (English).”
More from Karl-Johan Malmberg.